Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature
Pathologic complete response (pCR) after NC has been consistently associated with improved outcomes. Residual DCIS after NC does not portray worse prognosis compared to complete eradication of all disease but has clinical implications regarding surgical management. We report a case of pCR of DCIS as...
Saved in:
| Main Authors: | Sommer R. Gunia, Mita S. Patel, Eleftherios P. Mamounas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Surgery |
| Online Access: | http://dx.doi.org/10.1155/2012/454273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis
by: Eva L. Claassens, et al.
Published: (2025-04-01) -
Immunohistochemical Expression of ROS1 in invasive ductal carcinoma of breast in association with hormonal receptor status and Her2Neu expression
by: Muhammad Umair, et al.
Published: (2024-10-01) -
Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast
by: Dhivya Balaiya, et al.
Published: (2023-12-01) -
Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma: A Rare Case Report
by: Yu‐Kai Chang, et al.
Published: (2024-12-01) -
Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy
by: Qiuyu Yang, et al.
Published: (2025-07-01)